Transcription factor II H
Chr. 11 p15.1-p14 | |||||||
---|---|---|---|---|---|---|---|
|
Chr. 5 q12.2-13.3 | |||||||
---|---|---|---|---|---|---|---|
|
general transcription factor IIH, polypeptide 3, 34kDa | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Symbol | GTF2H3 | ||||||
Alt. symbols | BTF2, TFIIH | ||||||
Chr. 12 q24.31 | |||||||
|
Transcription factor II H (TFIIH) is an important
TFIIH consists of ten subunits, 7 of which (
Two other TFIIH subunits,
History of TFIIH
Before TFIIH identified it, it had several names. It was isolated in 1989 isolated from rat liver, known by factor transcription delta. When identified from cancer cells it was known that time as Basic transcription factor 2. Also, when isolated from yeast it was termed transcription factor B. Finally, in 1992 known as TFIIH.[4]
Structure of TFIIH
TFIIH is a ten‐subunit complex; seven of these subunits comprise the “core” whereas three comprise the dissociable “CAK” (CDK Activating Kinase) module.
Functions
General function of TFIIH:
(NER)TFIIH is a general transcription factor that acts to recruit RNA Pol II to the promoters of genes. It functions as a helicase that unwinds DNA. It also unwinds DNA after a DNA lesion has been recognized by either the global genome repair (GGR) pathway or the transcription-coupled repair (TCR) pathway of NER.[8][9] Purified TFIIH has role in stopping further RNA synthesis by activating the cyclic peptide α-amanitin.
Trichothiodystrophy
Mutation in genes ERCC3 (XPB), ERCC2 (XPD) or GTF2H5 (TTDA) cause trichothiodystrophy, a condition characterized by photosensitivity, ichthyosis, brittle hair and nails, intellectual impairment, decreased fertility and/or short stature.[10]
Disease
Genetic polymorphisms of genes that encode subunits of TFIIH are known to be associated with increased cancer susceptibility in many tissues, e.g.; skin tissue, breast tissue and lung tissue. Mutations in the subunits (such as XPD and XPB) can lead to a variety of diseases, including xeroderma pigmentosum (XP) or XP combined with Cockayne syndrome.[11] In addition to genetic variations, virus-encoded proteins also target TFIIH.[12]
DNA repair
TFIIH participates in nucleotide excision repair (NER) by opening the DNA double helix after damage is initially recognized. NER is a multi-step pathway that removes a wide range of different damages that distort normal base pairing, including bulky chemical damages and UV-induced damages. Individuals with mutational defects in genes specifying protein components that catalyze the NER pathway, including the TFIIH components, often display features of premature aging[10][13] (see DNA damage theory of aging).
Inhibitors
Potent, bioactive natural products like triptolide that inhibit mammalian transcription via inhibition of the XPB subunit of the general transcription factor TFIIH has been recently reported as a glucose conjugate for targeting hypoxic cancer cells with increased glucose transporter expression.[14]
Mechanism of TFIIH repairing DNA damaged sequence
![](http://upload.wikimedia.org/wikipedia/commons/thumb/6/6c/TFHII.pdf/page1-220px-TFHII.pdf.jpg)
References
External links
- Transcription+Factor+TFIIH at the U.S. National Library of Medicine Medical Subject Headings (MeSH)